Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douwe J Mulder

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 15, 2014
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery diseaseLisanne C de Vos, Douwe J Mulder, Andries J Smit, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup> C]TelmisartanSjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen, et al.
Cardiovascular Drugs and Therapy|March 8, 2007
The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stressDouwe J Mulder, Paul L van Haelst, Martgriet H Wobbes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2012
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery diseaseLisanne C de Vos, Marjon J Noordzij, Douwe J Mulder, et al.
Heliyon|November 26, 2020
Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot studyIsabella M Atzeni, Jeltje Boersema, Hendri H Pas, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Release of High-Mobility Group Box-1 after a Raynaud's Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis PathogenesisYehya Al-Adwi, Isabella M Atzeni, Berber Doornbos-van der Meer, et al.
Molecular Imaging and Biology|May 24, 2018
Performance Evaluation of a Semi-automated Method for [<sup>18</sup>F]FDG Uptake in Abdominal Visceral Adipose TissueStefanie A de Boer, Daan S Spoor, Riemer H J A Slart, et al.
Respiratory Research|October 3, 2025
GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosisBo Broens, Conny J van der Laken, Teodora Radonic, et al.
Plos One|December 31, 2013
Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosisMartijn A M den Dekker, Marjan Zwiers, Edwin R van den Heuvel, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE)Stefanie A de Boer, Hiddo J L Heerspink, Luis E Juárez Orozco, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|February 15, 2014
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery diseaseLisanne C de Vos, Douwe J Mulder, Andries J Smit, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup> C]TelmisartanSjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen, et al.
Cardiovascular Drugs and Therapy|March 8, 2007
The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stressDouwe J Mulder, Paul L van Haelst, Martgriet H Wobbes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2012
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery diseaseLisanne C de Vos, Marjon J Noordzij, Douwe J Mulder, et al.
Heliyon|November 26, 2020
Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot studyIsabella M Atzeni, Jeltje Boersema, Hendri H Pas, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Release of High-Mobility Group Box-1 after a Raynaud's Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis PathogenesisYehya Al-Adwi, Isabella M Atzeni, Berber Doornbos-van der Meer, et al.
Molecular Imaging and Biology|May 24, 2018
Performance Evaluation of a Semi-automated Method for [<sup>18</sup>F]FDG Uptake in Abdominal Visceral Adipose TissueStefanie A de Boer, Daan S Spoor, Riemer H J A Slart, et al.
Respiratory Research|October 3, 2025
GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosisBo Broens, Conny J van der Laken, Teodora Radonic, et al.
Plos One|December 31, 2013
Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosisMartijn A M den Dekker, Marjan Zwiers, Edwin R van den Heuvel, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE)Stefanie A de Boer, Hiddo J L Heerspink, Luis E Juárez Orozco, et al.
Pageof 8